So far for 2012, the NIH has approved 3,810 grants in Massachusetts – some for new projects, others for familiar, ongoing research centers. The big money is going to genetics, HIV/AIDS and biodefense. Few topped $10 million –according to NIH, the av
erage award amount nationwide was $44,642 for 2011. Among the group – genomics superstar Eric Lander, whose name cam
Here’s a look at the projects that, so far this year, have broken the $10 million mark – and a few that come close.e up during the recent presidential search at MIT and Daniel Kuritzkes at the Brigham, who got a standing ovation at the recent AIDS conference when he annouced findings on two more AIDS patinets who became virus-free after bone marrow transplants. Also note that Harvard Med School dean Jeffrey Flier is listed as the PI on the grant to the troubled primate research center.
Dana-Farber Jimmy Fund display
$35,860, 542 — Large Scale Sequencing and Analysis of Genomes Eric Lander, Broad Institute.
$30,578, 689 — AIDS Clinical Trials Group Network. Daniel Kuritzkes, Brigham and Women’s Hospital
$22,215,738 — Harvard Clinical and Translational Science Center, Lee Nadler, Harvard University Medical School
$17,236,951 — Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center. George Seage, Harvard University School of Public Health
$15,061,511 —Statistical and Data Management Center for the AIDS Clinical Trials Group. Michael Hughes, Harvard University School of Public Health
$12,739,167 — New England Primate Research Center Base Grant, Jeffrey Flier, Harvard Medical School
$11, 164, 583 — Cancer Center Support Grant. Edward Benz, Dana-Farber Cancer Institute
$10,719,999 — New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases, Dennis Kasper, Harvard.
$10,480,393 — Large Scale Sequencing and Analysis of Genomes. Eric Lander, Broad Institute.
Coming in just under the $10 million mark – BU’s National Emerging Infectious Diseases Laboratories – still not fully open
but pulling in $9.3 million. Right behind is BU, Paul Ricker’s Cardiovascular Inflammation Reduction Trial (CIRT) at the Brigham, with $8,957,197.